These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8944206

  • 21. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
    Todd JF, Edwards CM, Ghatei MA, Mather HM, Bloom SR.
    Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes.
    Nauck MA.
    Horm Metab Res; 2004 Sep; 36(11-12):852-8. PubMed ID: 15655719
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Glimepiride (Amaryl): a review of its pharmacological and clinical profile].
    Bando K, Yamada Y.
    Nihon Yakurigaku Zasshi; 2001 Jul; 118(1):59-67. PubMed ID: 11496829
    [Abstract] [Full Text] [Related]

  • 29. Human studies with glucagon-like-peptide-1: potential of the gut hormone for clinical use.
    Byrne MM, Göke B.
    Diabet Med; 1996 Oct; 13(10):854-60. PubMed ID: 8911778
    [Abstract] [Full Text] [Related]

  • 30. Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.
    Kumar A.
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():21-5. PubMed ID: 23280862
    [Abstract] [Full Text] [Related]

  • 31. Advances in the treatment of type 2 diabetes mellitus.
    Israili ZH.
    Am J Ther; 2011 Dec; 18(2):117-52. PubMed ID: 19834322
    [Abstract] [Full Text] [Related]

  • 32. Management of antidiabetic medications in overdose.
    Spiller HA.
    Drug Saf; 1998 Nov; 19(5):411-24. PubMed ID: 9825953
    [Abstract] [Full Text] [Related]

  • 33. New drugs for type 2 diabetes mellitus: what is their place in therapy?
    Krentz AJ, Patel MB, Bailey CJ.
    Drugs; 2008 Nov; 68(15):2131-62. PubMed ID: 18840004
    [Abstract] [Full Text] [Related]

  • 34. Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue.
    Uçkaya G, Delagrange P, Chavanieu A, Grassy G, Berthault MF, Ktorza A, Cerasi E, Leibowitz G, Kaiser N.
    J Endocrinol; 2005 Mar; 184(3):505-13. PubMed ID: 15749809
    [Abstract] [Full Text] [Related]

  • 35. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
    Ryan GJ, Jobe LJ, Martin R.
    Clin Ther; 2005 Oct; 27(10):1500-12. PubMed ID: 16330288
    [Abstract] [Full Text] [Related]

  • 36. Effects of current therapeutic interventions on insulin resistance.
    Kobayashi M.
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S32-40. PubMed ID: 11220286
    [Abstract] [Full Text] [Related]

  • 37. [Postprandial hyperglycemia. II. Pharmacological approaches].
    Scheen AJ, Letiexhe MR, Geronooz I, Paquot N, Jandrain B.
    Rev Med Liege; 2002 Apr; 57(4):196-201. PubMed ID: 12073790
    [Abstract] [Full Text] [Related]

  • 38. Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.
    Nauck MA, Meier JJ.
    Regul Pept; 2005 Jun 15; 128(2):135-48. PubMed ID: 15780433
    [Abstract] [Full Text] [Related]

  • 39. Antihyperglycaemic agents. Drug interactions of clinical importance.
    Scheen AJ, Lefèbvre PJ.
    Drug Saf; 1995 Jan 15; 12(1):32-45. PubMed ID: 7741982
    [Abstract] [Full Text] [Related]

  • 40. Can alpha-glucosidase inhibitors reduce the dosage of sulphonylurea compounds needed by patients with non-insulin-dependent diabetes mellitus?
    Okada S, Ishii K, Tanokuchi S, Hamada H, Ichiki K, Ota Z.
    J Int Med Res; 1995 Jan 15; 23(6):502-7. PubMed ID: 8746620
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.